'Novo Nordisk has become Europe’s most valuable company based on closing prices for the first time, after the Danish pharmaceutical group introduced its best-selling weight-loss drug Wegovy in the UK'

https://www.ft.com/content/19357584-62e0-452f-a06f-7cda1d8cd0e3